Tekla Capital Management’s Yarrow Bioscience YARW Stock Holding History

Tekla Capital Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$30.5K	Hold	150	–	–	﹤0.01%	164
2023 Q1	$23.2K	Hold	150	–	–	﹤0.01%	175
2022 Q4	$20.3K	Hold	150	–	–	﹤0.01%	168
2022 Q3	$30K	Hold	150	–	–	﹤0.01%	164
2022 Q2	$53K	Hold	150	–	–	﹤0.01%	173
2022 Q1	$88K	Hold	150	–	–	﹤0.01%	170
2021 Q4	$138K	Hold	150	–	–	﹤0.01%	166
2021 Q3	$188K	Hold	150	–	–	0.01%	168
2021 Q2	$475K	Hold	150	–	–	0.02%	182
2021 Q1	$927K	Hold	150	–	–	0.03%	178
2020 Q4	$856K	Hold	150	–	–	0.03%	185
2020 Q3	$899K	Hold	150	–	–	0.03%	183
2020 Q2	$937K	Buy	150 +101	+206%	+$684K	0.04%	195
2020 Q1	$478K	Buy	+49	New	+$769K	0.02%	198
2018 Q4	–	Sell	-7	Closed	-$244K	–	211
2018 Q3	$244K	Buy	+7	New	+$216K	0.01%	207

Other funds holding YARW

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tekla Capital Management's YARW Position: Q2 2023 in Review

Tekla Capital Management held its Yarrow Bioscience (YARW) position steady in Q2 2023 at 150 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

Tekla Capital Management first reported a position in YARW in Q3 2018 and has held it in 15 quarters since. The position peaked at $937K in Q2 2020. 17 funds tracked by Wall St. Rank hold YARW as of Q2 2023.

Tekla Capital Management held 150 shares of Yarrow Bioscience worth $30.5K as of Q2 2023.
Tekla Capital Management left its Yarrow Bioscience share count unchanged in Q2 2023.
Yarrow Bioscience made up ﹤0.01% of Tekla Capital Management's portfolio in Q2 2023, its #164 holding.
Tekla Capital Management first reported a position in Yarrow Bioscience in Q3 2018 and has held it in 15 quarters since.
Tekla Capital Management's Yarrow Bioscience position peaked at $937K in Q2 2020.
17 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.